Bridging the evidence-to-practice gap: A call to end routine lab testing for isotretinoin

Adults and adolescents without risk factors for hepatic or pancreatic conditions prescribed isotretinoin for acne should not be required to undergo routine laboratory testing, according to a viewpoint published in JAMA Dermatology. The motivations behind streamlining these clinical practices are to ease patient health anxiety, reduce the financial burden on patients and align more closely with